GediPNet logo

FN1 (fibronectin 1)

Gene
Entrez ID Entrez Gene ID - the GENE ID in NCBI Gene database.
2335
Gene nameGene Name - the full gene name approved by the HGNC.
Fibronectin 1
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
FN1
SynonymsGene synonyms aliases
CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF, SMDCF
ChromosomeChromosome number
2
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
2q35
SummarySummary of gene provided in NCBI Entrez Gene.
This gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. The encoded preproprotein is proteolytically processed to generate the mature protein. Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis. The gene has three regions subject to alternative splicing, with the potential to produce 20 different transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. The full-length nature of some variants has not been determined. [provided by RefSeq, Jan 2016]
SNPsSNP information provided by dbSNP.
SNP ID Visualize variation Clinical significance Consequence
rs113683179 C>G,T Pathogenic Splice donor variant
rs137854488 T>C Pathogenic Missense variant, coding sequence variant, genic downstream transcript variant
rs797044906 C>A Pathogenic Coding sequence variant, missense variant, genic downstream transcript variant
rs869025199 GAG>- Pathogenic Inframe deletion, coding sequence variant, genic downstream transcript variant
rs1064795155 G>C Likely-pathogenic Missense variant, coding sequence variant
miRNAmiRNA information provided by mirtarbase database.
miRTarBase ID miRNA Experiments Reference
MIRT003959 hsa-miR-200c-3p Microarray 17875710
MIRT003959 hsa-miR-200c-3p Immunoblot, Luciferase reporter assay, qRT-PCR, Western blot 21501518
MIRT003959 hsa-miR-200c-3p Immunohistochemistry, Luciferase reporter assay, qRT-PCR, Western blot 28113080
MIRT004009 hsa-miR-200b-3p Microarray 17875710
MIRT004009 hsa-miR-200b-3p Luciferase reporter assay, qRT-PCR, Western blot 23408168
Transcription factors
Transcription factor Regulation Reference
AR Unknown 21055159
ATF2 Unknown 10471826
CEBPA Unknown 1320003
EGR1 Activation 15608673;9933644
EGR1 Unknown 10783396
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
GO ID Ontology Definition Evidence Reference
GO:0001525 Process Angiogenesis IEA
GO:0001932 Process Regulation of protein phosphorylation IDA 11792823
GO:0002020 Function Protease binding IPI 22952693
GO:0002576 Process Platelet degranulation TAS
GO:0005102 Function Signaling receptor binding IBA 21873635
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
MIM
HGNC
e!Ensembl
Protein
UniProt ID P02751
Protein name Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]
Protein function Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin (PubMed:3024962, PubMed:3900070, PubMed:3593230, PubMed:7989369). Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape (PubMed:3024962, PubMed:3900070, PubMed:3593230, PubMed:7989369). Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization (By similarity). Participates in the regulation of type I collagen deposition by osteoblasts (By similarity). ; [Anastellin]: Binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling.
PDB 1E88 , 1E8B , 1FBR , 1FNA , 1FNF , 1FNH , 1J8K , 1O9A , 1OWW , 1Q38 , 1QGB , 1QO6 , 1TTF , 1TTG , 2CG6 , 2CG7 , 2CK2 , 2CKU , 2EC3 , 2FN2 , 2FNB , 2GEE , 2H41 , 2H45 , 2HA1 , 2MNU , 2N1K , 2OCF , 2RKY , 2RKZ , 2RL0 , 3CAL , 3EJH , 3GXE , 3M7P , 3MQL , 3R8Q , 3T1W , 3ZRZ , 4GH7 , 4JE4 , 4JEG , 4LXO , 4MMX , 4MMY , 4MMZ , 4PZ5 , 5DC0 , 5DC4 , 5DC9 , 5DFT
Family and domains

Pfam

Accession ID Position in sequence Description Type
PF00039 fn1
52 87
Fibronectin type I domain
Domain
PF00039 fn1
97 135
Fibronectin type I domain
Domain
PF00039 fn1
141 179
Fibronectin type I domain
Domain
PF00039 fn1
186 225
Fibronectin type I domain
Domain
PF00039 fn1
231 270
Fibronectin type I domain
Domain
PF00039 fn1
308 342
Fibronectin type I domain
Domain
PF00040 fn2
360 401
Fibronectin type II domain
Domain
PF00040 fn2
420 461
Fibronectin type II domain
Domain
PF00039 fn1
470 508
Fibronectin type I domain
Domain
PF00039 fn1
518 555
Fibronectin type I domain
Domain
PF00039 fn1
561 599
Fibronectin type I domain
Domain
PF00041 fn3
609 692
Fibronectin type III domain
Domain
PF00041 fn3
723 801
Fibronectin type III domain
Domain
PF00041 fn3
812 891
Fibronectin type III domain
Domain
PF00041 fn3
908 988
Fibronectin type III domain
Domain
PF00041 fn3
998 1078
Fibronectin type III domain
Domain
PF00041 fn3
1093 1163
Fibronectin type III domain
Domain
PF00041 fn3
1175 1258
Fibronectin type III domain
Domain
PF00041 fn3
1268 1349
Fibronectin type III domain
Domain
PF00041 fn3
1359 1439
Fibronectin type III domain
Domain
PF00041 fn3
1449 1530
Fibronectin type III domain
Domain
PF00041 fn3
1543 1623
Fibronectin type III domain
Domain
PF00041 fn3
1633 1713
Fibronectin type III domain
Domain
PF00041 fn3
1723 1803
Fibronectin type III domain
Domain
PF00041 fn3
1815 1894
Fibronectin type III domain
Domain
PF00041 fn3
1904 1984
Fibronectin type III domain
Domain
PF00041 fn3
2110 2182
Fibronectin type III domain
Domain
PF00039 fn1
2206 2245
Fibronectin type I domain
Domain
PF00039 fn1
2251 2288
Fibronectin type I domain
Domain
PF00039 fn1
2295 2330
Fibronectin type I domain
Domain
Sequence
MLRGPGPGLLLLAVQCLGTAVPSTGASKSKRQAQQMVQPQSPVAVSQSKPGCYDNGKHYQ
INQQWERTYLGNALVCTCYGGSRGFNC
ESKPEAEETCFDKYTGNTYRVGDTYERPKDSMI
WDCTCIGAGRGRISC
TIANRCHEGGQSYKIGDTWRRPHETGGYMLECVCLGNGKGEWTCK
PIAEKCFDHAAGTSYVVGETWEKPYQGWMMVDCTCLGEGSGRITCTSRNRCNDQDTRTSY
RIGDTWSKKDNRGNLLQCICTGNGRGEWKC
ERHTSVQTTSSGSGPFTDVRAAVYQPQPHP
QPPPYGHCVTDSGVVYSVGMQWLKTQGNKQMLCTCLGNGVSCQETAVTQTYGGNSNGEPC
VLPFTYNGRTFYSCTTEGRQDGHLWCSTTSNYEQDQKYSFC
TDHTVLVQTRGGNSNGALC
HFPFLYNNHNYTDCTSEGRRDNMKWCGTTQNYDADQKFGFC
PMAAHEEICTTNEGVMYRI
GDQWDKQHDMGHMMRCTCVGNGRGEWTC
IAYSQLRDQCIVDDITYNVNDTFHKRHEEGHM
LNCTCFGQGRGRWKC
DPVDQCQDSETGTFYQIGDSWEKYVHGVRYQCYCYGRGIGEWHCQ
PLQTYPSSSGPVEVFITETPSQPNSHPIQWNAPQPSHISKYILRWRPKNSVGRWKEATIP
GHLNSYTIKGLKPGVVYEGQLISIQQYGHQEV
TRFDFTTTSTSTPVTSNTVTGETTPFSP
LVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDL
LPGRKYIVNVYQISEDGEQSL
ILSTSQTTAPDAPPDTTVDQVDDTSIVVRWSRPQAPITG
YRIVYSPSVEGSSTELNLPETANSVTLSDLQPGVQYNITIYAVEENQESTP
VVIQQETTG
TPRSDTVPSPRDLQFVEVTDVKVTIMWTPPESAVTGYRVDVIPVNLPGEHGQRLPISRNT
FAEVTGLSPGVTYYFKVFAVSHGRESKP
LTAQQTTKLDAPTNLQFVNETDSTVLVRWTPP
RAQITGYRLTVGLTRRGQPRQYNVGPSVSKYPLRNLQPASEYTVSLVAIKGNQESPKA
TG
VFTTLQPGSSIPPYNTEVTETTIVITWTPAPRIGFKLGVRPSQGGEAPREVTSDSGSIVV
SGLTPGVEYVYTIQVLRDGQERD
APIVNKVVTPLSPPTNLHLEANPDTGVLTVSWERSTT
PDITGYRITTTPTNGQQGNSLEEVVHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVP
IS
DTIIPEVPQLTDLSFVDITDSSIGLRWTPLNSSTIIGYRITVVAAGEGIPIFEDFVDSSV
GYYTVTGLEPGIDYDISVITLINGGESAP
TTLTQQTAVPPPTDLRFTNIGPDTMRVTWAP
PPSIDLTNFLVRYSPVKNEEDVAELSISPSDNAVVLTNLLPGTEYVVSVSSVYEQHEST
P
LRGRQKTGLDSPTGIDFSDITANSFTVHWIAPRATITGYRIRHHPEHFSGRPREDRVPHS
RNSITLTNLTPGTEYVVSIVALNGREESPL
LIGQQSTVSDVPRDLEVVAATPTSLLISWD
APAVTVRYYRITYGETGGNSPVQEFTVPGSKSTATISGLKPGVDYTITVYAVTGRGDSPA
SSK
PISINYRTEIDKPSQMQVTDVQDNSISVKWLPSSSPVTGYRVTTTPKNGPGPTKTKT
AGPDQTEMTIEGLQPTVEYVVSVYAQNPSGESQ
PLVQTAVTNIDRPKGLAFTDVDVDSIK
IAWESPQGQVSRYRVTYSSPEDGIHELFPAPDGEEDTAELQGLRPGSEYTVSVVALHDDM
ESQ
PLIGTQSTAIPAPTDLKFTQVTPTSLSAQWTPPNVQLTGYRVRVTPKEKTGPMKEIN
LAPDSSSVVVSGLMVATKYEVSVYALKDTLTSRP
AQGVVTTLENVSPPRRARVTDATETT
ITISWRTKTETITGFQVDAVPANGQTPIQRTIKPDVRSYTITGLQPGTDYKIYLYTLNDN
ARSS
PVVIDASTAIDAPSNLRFLATTPNSLLVSWQPPRARITGYIIKYEKPGSPPREVVP
RPRPGVTEATITGLEPGTEYTIYVIALKNNQKSEPLIGRKKTDELPQLVTLPHPNLHGPE
ILDVPSTVQKTPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFRRTTPPTTATPI
RHRPRPYPPNVGEEIQIGHIPR
EDVDYHLYPHGPGLNPNASTGQEALSQTTISWAPFQDT
SEYIISCHPVGTDEEPLQFRVPGTS
TSATLTGLTRGATYNVIVEALKDQQRHKVREEVVT
VGNSVNEG
LNQPTDDSCFDPYTVSHYAVGDEWERMSESGFKLLCQCLGFGSGHFRCDSSR
WCHDNGVNYKIGEKWDRQGENGQMMSCTCLGNGKGEFKCDPHEATCYDDGKTYHVGEQWQ
KEYLGAICSCTCFGGQRGWRCDNCRRPGGEPSPEGTTGQSYNQYSQRYHQRTNTNVNCPI
ECFMPLDVQADREDSRE
Sequence length 2477
Interactions View interactions

| © 2021, Biomedical Informatics Centre, NIRRH |
ICMR-National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400012
Tel: +91-22-24192104, Fax No: +91-22-24139412